Pfizer, BioNTech Start Work On Next-Gen COVID-19 Vaccine Candidate For Broader Protection

By: via Benzinga
Pfizer Inc(NYSE: PFE) andBioNTech SE(NASDAQ: BNTX) have initiated a Phase 1 study to evaluate the safety, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.